Anthem Biosciences
ANTHEM · Pharma > Pharmaceuticals & Drugs Listing date: July 21, 2025

Stock Price vs Company Growth
1d
1.9%
1w
3.0%
1m
1.7%
3m
7.7%
6m
19.7%
all
3.6%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 757 1.9%
608
826
Company Overview

Sales
2,124 Cr
Growth: 9.8%
Profit after Tax
591 Cr
Growth: 21.9%
Large Cap
42,620 Cr
P/E: 72.3x
Industry P/E: 31.1x
Fundamentals

Sales (Cr) ₹ 2,124
Growth 9.8%
EBITDA 39.3%
P/S 20.1x
Dividend 0.0%
P/E 72.3x
Book Value ₹ 54
PEG Ratio 7.4x
ROE 21.3%
P/B 14.0x
Shareholding Pattern

Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed

Anthem Biosciences has been set up as a Life sciences/ Biotechnology based venture specialising in the manufacture of catalytic preparation, other organic compounds such as speciality organic molecules, biologically active peptides etc., which are high-value products used in drug, agrochemical and speciality chemicals industries. Awards, accreditations, and recognition2023: Received a certificate of recognition as a ‘Four Star Export House’ from the Ministry of Commerce and Industry.
Investors (1)
Followers (1)